---
kind: "section"
citation: "21 U.S.C. § 1704"
title: "21"
title_heading: "Food and Drugs"
number: "1704"
heading: "Coordination with National Drug Control Program agencies in demand reduction, supply reduction, and State and local affairs"
release: "119-102"
date: "2026-07-12"
url: "https://uscodex.org/usc/21/1704"
units:
  - "Chapter 22 — National Drug Control Policy"
---

# §1704. Coordination with National Drug Control Program agencies in demand reduction, supply reduction, and State and local affairs

- (a) **Access to information—**
  - (1) **In general—** Upon the request of the [Director](/usc/21/1701.md?p=4), the head of any [National Drug Control Program agency](/usc/21/1701.md?p=11) shall cooperate with and provide to the [Director](/usc/21/1701.md?p=4) any statistics, studies, reports, and other information prepared or collected by the [agency](/usc/21/1701.md?p=1) concerning the responsibilities of the [agency](/usc/21/1701.md?p=1) under the [National Drug Control Strategy](/usc/21/1701.md?p=12) that relate to—
    - (A) [drug control](/usc/21/1701.md?p=6); or
    - (B) the manner in which amounts made available to that [agency](/usc/21/1701.md?p=1) for [drug control](/usc/21/1701.md?p=6) are being used by that [agency](/usc/21/1701.md?p=1).
  - (2) **Protection of intelligence information—**
    - (A) **In general—** The authorities conferred on the [Office](/usc/21/1701.md?p=14) and the [Director](/usc/21/1701.md?p=4) by this chapter shall be exercised in a manner consistent with provisions of the National Security Act of 1947 [[50 U.S.C. 3001](/usc/50/3001.md) et seq.]. The [Director](/usc/21/1701.md?p=4) of National Intelligence shall prescribe such regulations as may be necessary to protect information provided pursuant to this chapter regarding intelligence sources and methods.
    - (B) **Duties of Director—** The [Director](/usc/21/1701.md?p=4) of National Intelligence and the [Director](/usc/21/1701.md?p=4) of the Central Intelligence [Agency](/usc/21/1701.md?p=1) shall, to the maximum extent practicable in accordance with [subparagraph (A)](#a-2-A), render full assistance and support to the [Office](/usc/21/1701.md?p=14) and the [Director](/usc/21/1701.md?p=4).
  - (3) **Required reports—**
    - (A) **Secretaries of the Interior and Agriculture—** Not later than July 1 of each year, the Secretaries of Agriculture and the Interior shall jointly submit to the [Director](/usc/21/1701.md?p=4) and the [appropriate congressional committees](/usc/21/1701.md?p=2-A) an assessment of the quantity of illegal [drug](/usc/21/1701.md?p=5) cultivation and manufacturing in the United States on lands owned or under the jurisdiction of the Federal Government for the preceding year.
    - (B) **Secretary of Homeland Security—** Not later than July 1 of each year, the Secretary of Homeland Security shall submit to the [Director](/usc/21/1701.md?p=4) and the [appropriate congressional committees](/usc/21/1701.md?p=2-A) information for the preceding year regarding—
      - (i) the number and type of seizures of [drugs](/usc/21/1701.md?p=5) by each component of the Department of Homeland Security seizing [drugs](/usc/21/1701.md?p=5), as well as statistical information on the geographic areas of such seizures; and
      - (ii) the number of air and maritime patrol hours primarily dedicated to [drug](/usc/21/1701.md?p=5) [supply reduction](/usc/21/1701.md?p=17) missions undertaken by each component of the Department of Homeland Security.
    - (C) **Secretary of Defense—** The Secretary of Defense shall, by July 1 of each year, submit to the [Director](/usc/21/1701.md?p=4) and the [appropriate congressional committees](/usc/21/1701.md?p=2-A) information for the preceding year regarding the number of air and maritime patrol hours primarily dedicated to [drug](/usc/21/1701.md?p=5) [supply reduction](/usc/21/1701.md?p=17) missions undertaken by each component of the Department of Defense.
    - (D) **Attorney General—** The Attorney General shall, by July 1 of each year, submit to the [Director](/usc/21/1701.md?p=4) and the [appropriate congressional committees](/usc/21/1701.md?p=2-A) information for the preceding year regarding the number and type of—
      - (i) arrests for [drug](/usc/21/1701.md?p=5) violations;
      - (ii) prosecutions for [drug](/usc/21/1701.md?p=5) violations by United States Attorneys; and
      - (iii) seizures of [drugs](/usc/21/1701.md?p=5) by each component of the Department of Justice seizing [drugs](/usc/21/1701.md?p=5), as well as statistical information on the geographic areas of such seizures.
- (b) **Certification of policy changes to Director—**
  - (1) **In general—** Subject to [paragraph (2)](#b-2), the head of a [National Drug Control Program agency](/usc/21/1701.md?p=11) shall, unless exigent circumstances require otherwise, notify the [Director](/usc/21/1701.md?p=4) in writing regarding any proposed change in policies relating to the activities of that [agency](/usc/21/1701.md?p=1) under the [National Drug Control Program](/usc/21/1701.md?p=10) prior to implementation of such change. The [Director](/usc/21/1701.md?p=4) shall promptly review such proposed change and certify to the head of that [agency](/usc/21/1701.md?p=1) in writing whether such change is consistent with the [National Drug Control Strategy](/usc/21/1701.md?p=12).
  - (2) **Exception—** If prior notice of a proposed change under [paragraph (1)](#b-1) is not practicable—
    - (A) the head of the [National Drug Control Program agency](/usc/21/1701.md?p=11) shall notify the [Director](/usc/21/1701.md?p=4) of the proposed change as soon as practicable; and
    - (B) upon such notification, the [Director](/usc/21/1701.md?p=4) shall review the change and certify to the head of that [agency](/usc/21/1701.md?p=1) in writing whether the change is consistent with the [National Drug Control Strategy](/usc/21/1701.md?p=12).
- (c) **General Services Administration—** The Administrator of General Services shall provide to the [Director](/usc/21/1701.md?p=4), on a reimbursable basis, such administrative support services as the [Director](/usc/21/1701.md?p=4) may request.
- (d) **Accounting of funds expended—**
  - (1) **In general—** Not later than February 1 of each year, in accordance with guidance issued by the [Director](/usc/21/1701.md?p=4), the head of each [National Drug Control Program agency](/usc/21/1701.md?p=11) shall submit to the [Director](/usc/21/1701.md?p=4) a detailed accounting of all funds expended by the [agency](/usc/21/1701.md?p=1) for [National Drug Control Program](/usc/21/1701.md?p=10) activities during the previous fiscal year and shall ensure such detailed accounting is authenticated for the previous fiscal year by the Inspector General for such [agency](/usc/21/1701.md?p=1) prior to the submission to the [Director](/usc/21/1701.md?p=4) as frequently as determined by the Inspector General but not less frequently than every 3 years.
  - (2) **Submission to Congress—** The [Director](/usc/21/1701.md?p=4) shall submit to Congress not later than April 1 of each year the information submitted to the [Director](/usc/21/1701.md?p=4) under [paragraph (1)](#d-1).
- (e) **Drug court training and technical assistance program—**
  - (1) **Grants authorized—** The [Director](/usc/21/1701.md?p=4) may make a grant to a [nonprofit organization](/usc/21/1701.md?p=13) for the purpose of providing training and technical assistance to [drug](/usc/21/1701.md?p=5) courts.
  - (2) **Authorization of appropriations—** There is authorized to be appropriated to carry out this subsection $2,000,000 for each of fiscal years 2018 through 2023.
- (f) **Tracking system for federally funded grant programs—**
  - (1) **Establishment—** The [Director](/usc/21/1701.md?p=4), or the head of an [agency](/usc/21/1701.md?p=1) designated by the [Director](/usc/21/1701.md?p=4), in coordination with the Secretary of Health and Human Services, shall track federally-funded grant programs to—
    - (A) ensure the public has electronic access to information identifying:
      - (i) all [drug control](/usc/21/1701.md?p=6) grants and pertinent identifying information for each grant; and
      - (ii) any available performance metrics, evaluations, or other information indicating the effectiveness of such programs;
    - (B) facilitate efforts to identify duplication, overlap, or gaps in funding to provide increased accountability of Federally-funded grants for [substance use disorder treatment](/usc/21/1701.md?p=16), prevention, and enforcement; and
    - (C) identify barriers that may impede applicants in the grant application process.
  - (2) **National Drug Control Program Agencies—** The head of each [National Drug Control Program agency](/usc/21/1701.md?p=11) shall provide to the [Director](/usc/21/1701.md?p=4) a complete list of all [drug control](/usc/21/1701.md?p=6) program grant programs and any other relevant information for inclusion in the system developed under [paragraph (1)](#f-1) and annually update such list.
  - (3) **Updating existing systems—** The [Director](/usc/21/1701.md?p=4) may meet the requirements of this subsection by utilizing, updating, or improving existing Federal information systems to ensure they meet the requirements of this subsection.
  - (4) **Report—** Not later than 3 years after October 24, 2018, the Comptroller General of the United States shall submit to Congress a report examining implementation of this subsection.

## Source credit

(Pub. L. 105–277, div. C, title VII, §§ 705, 715, Oct. 21, 1998, 112 Stat. 2681–680, 2681–693; Pub. L. 109–469, title I, § 104, title VI, § 602, Dec. 29, 2006, 120 Stat. 3510, 3533; Pub. L. 115–271, title VIII, §§ 8202(a), (b)(2), 8207, 8217(g), Oct. 24, 2018, 132 Stat. 4110, 4113, 4124; Pub. L. 116–74, § 2(a)(1), (6), Nov. 27, 2019, 133 Stat. 1155, 1156.)

## Notes

### Editorial Notes

### References in Text

The National Security Act of 1947, referred to in subsec. (a)(2)(A), is act July 26, 1947, ch. 343, 61 Stat. 495, which was formerly classified principally to chapter 15 (§ 401 et seq.) of Title 50, War and National Defense, prior to editorial reclassification in Title 50, and is now classified principally to chapter 44 (§ 3001 et seq.) of Title 50. For complete classification of this Act to the Code, see Tables.

### Amendments

2019—Pub. L. 116–74, § 2(a)(1), substituted “National Drug Control Program agency” for “National Drug Control Program Agency” wherever appearing.

Subsec. (d)(1). Pub. L. 116–74, § 2(a)(6)(A), substituted “than every” for “that every”.

Subsec. (f)(1)(A)(i). Pub. L. 116–74, § 2(a)(6)(B)(i)(I), substituted “grant; and” for “grant;”.

Subsec. (f)(1)(C). Pub. L. 116–74, § 2(a)(6)(B)(i)(II), inserted “that may impede applicants” after “barriers” and struck out “impediments that applicants currently have in the grant application process with applicable agencies” before period at end.

Subsec. (f)(2). Pub. L. 116–74, § 2(a)(6)(B)(ii), substituted “Drug Control Program” for “Drug Control” in heading.

2018—Pub. L. 115–271, § 8202(b)(2), repealed Pub. L. 105–277, § 715. See 1998 Amendment note below.

Pub. L. 115–271, § 8202(a), revived and restored this section as in effect on Sept. 29, 2003, and as amended by Pub. L. 109–469 and Pub. L. 112–166. See Reauthorization of the Office of National Drug Control Policy note set out under section 1701 of this title.

Subsec. (d). Pub. L. 115–271, § 8217(g)(1), amended subsec. (d) generally. Prior to amendment, text read as follows: “The Director shall—

“(A) require the National Drug Control Program agencies to submit to the Director not later than February 1 of each year a detailed accounting of all funds expended by the agencies for National Drug Control Program activities during the previous fiscal year, and require such accounting to be authenticated by the Inspector General for each agency prior to submission to the Director; and

“(B) submit to Congress not later than April 1 of each year the information submitted to the Director under subparagraph (A).”

Subsec. (e). Pub. L. 115–271, § 8207, added subsec. (e).

Subsec. (f). Pub. L. 115–271, § 8217(g)(2), added subsec. (f).

2006—Pub. L. 109–469, § 602, amended Pub. L. 105–277, § 715, which provided for the repeal of this section. See 1998 Amendment note below.

Subsec. (a)(1)(A). Pub. L. 109–469, § 104(1), struck out “abuse” after “drug”.

Subsec. (a)(2)(A). Pub. L. 109–469, § 104(2), substituted “Director of National Intelligence” for “Director of Central Intelligence”.

Subsec. (a)(2)(B). Pub. L. 109–469, § 104(3), substituted “Director of National Intelligence and the Director of the Central Intelligence Agency” for “Director of Central Intelligence”.

Subsec. (a)(3). Pub. L. 109–469, § 104(4), amended par. (3) generally. Prior to amendment, text read as follows: “The Secretary of Agriculture shall annually submit to the Director an assessment of the acreage of illegal drug cultivation in the United States.”

Subsec. (b)(2)(B). Pub. L. 109–469, § 104(5), substituted “Strategy” for “Program”.

Subsec. (c). Pub. L. 109–469, § 104(6), substituted “on” for “in”.

1998—Pub. L. 105–277, § 715, as amended by Pub. L. 109–469, § 602, which provided for the repeal of this section effective Sept. 30, 2010, was repealed by Pub. L. 115–271, § 8202(b)(2). See former section 1712 of this title.